Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype

References

• Edelmann J, Klein-Hitpass L, Carpinteiro A, . Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res 2008;32: 1565–1572.
   PubMed Web of Science ®Google Scholar
• Ghia P, Granziero L, Chilosi M, . Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol 2002;12: 149–155.
   PubMed Web of Science ®Google Scholar
• Rosati S, Kluin PM.Chronic lymphocytic leukaemia: a review of the immuno-architecture. Curr Top Microbiol Immunol 2005;294: 91–107.
   PubMed Web of Science ®Google Scholar
• Hazan-Halevy I, Harris D, Liu Z, . STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood 2010;115:2852–2863.
   PubMed Web of Science ®Google Scholar
• Longo PG, Laurenti L, Gobessi S, . The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008;111:846–855.
   PubMed Web of Science ®Google Scholar
• Furman RR, Asgary Z, Mascarenhas JO, . Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 2000;164:2200–2206.
   PubMed Web of Science ®Google Scholar
• Wickremasinghe RG, Prentice AG, Steele AJ. Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. Br J Haematol 2011;153:545–556.
   PubMed Web of Science ®Google Scholar
• Burger JA. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2011:96–103.
   Google Scholar
• Van den Hove LE, Van Gool SW, Vandenberghe P, . CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 1997;11:572–580.
   PubMedGoogle Scholar
• Cuni S, Perez-Aciego P, Perez-Chacon G, . A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004;18:1391–1400.
   PubMed Web of Science ®Google Scholar
• Hertlein E, Wagner AJ, Jones J, . 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood 2010;116:45–53.
   PubMed Web of Science ®Google Scholar
• Best OG, Singh N, Forsyth C, . The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway. Br J Haematol 2010;151:185–188.
   PubMed Web of Science ®Google Scholar
• Best OG, Che Y, Singh N, . The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease. Leuk Lymphoma 2012 Jan 31. [Epub ahead of print]
   Google Scholar
• Best OG, Gardiner AC, Majid A, . A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL. Leukemia 2008;22:1456–1459.
   PubMed Web of Science ®Google Scholar
• Damle RN, Wasil T, Fais F, . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
   PubMed Web of Science ®Google Scholar
• Orchard JA, Ibbotson RE, Davis Z, . ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004;363: 105–111.
   PubMed Web of Science ®Google Scholar
• Buhmann R, Nolte A, Westhaus D, . CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 1999;93:1992–2002.
   PubMed Web of Science ®Google Scholar
• Deaglio S, Capobianco A, Bergui L, . CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 2003; 102:2146–2155.
   PubMed Web of Science ®Google Scholar
• Damle RN, Ghiotto F, Valetto A, . B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002;99:4087–4093.
   PubMed Web of Science ®Google Scholar
• Ahmed-Choudhury J, Williams KT, Young LS, . CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2. Cell Signal 2006;18:456–468.
   PubMed Web of Science ®Google Scholar
• Li P, Harris D, Liu Z, . Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS One 2010;5:e11859.
   PubMed Web of Science ®Google Scholar
• Daneshmanesh AH, Mikaelsson E, Jeddi-Tehrani M, . Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int J Cancer 2008;123:1190–1195.
   PubMed Web of Science ®Google Scholar
• Kurtova AV, Balakrishnan K, Chen R, . Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009;114:4441–4450.
   PubMed Web of Science ®Google Scholar
• Castro JE, Prada CE, Loria O, . ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood 2005;106:2506–2512.
   PubMed Web of Science ®Google Scholar
• McCaig AM, Cosimo E, Leach MT, . Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals. Br J Haematol 2011;153:199–211.
   PubMed Web of Science ®Google Scholar